Investigations in Gynecology Research & Womens Health

Phyllodes Tumors: What is the Best Therapeutic Option?

  • Open or Close Camyllade Souza Landal*

    Academic of University of Vale do Itajaí, Brazil

    *Corresponding author: Camyllade Souza Landal, Academic of University of Vale do Itajaí, Itajaí, Brazil, Tel: 5547996269596; Email: camyllalandal@gmail.com

Submission: February 11, 2017; Published: March 13, 2018

ISSN: 2577-2015
Volume1 Issue5


Phyllodes tumors of the breast are a rare tumor, accounting for only 1% of breast tumors. It has a fast growth, resembling fibro adenoma in its shape. It is classified as benign, borderline and malignant. It has a high relapse rate, with 27% in malignant tumors. And globally they metastasize in about 4% of the cases, being usually hematologically. From the moment of the diagnosis made by the anatomopathological study, the best therapeutic option consists of surgical resection with free safety margins, and it can be extended to mastectomy without axillary dissection in the case of malignancy or tumors with a larger diameter. The use of adjuvant therapies still remains questioned.

Keywords: Phyllodes tumors; Breast neoplasms; Therapeutics

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • Third Avenue, 2nd floor,
  •     New York - 10016, USA
  • +1 (929) 600-8049
  • +1 (929) 296-7519
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com

Editorial Office